Hinweis-Modus ist eingeschaltet Ausschalten

SBIO - Invesco NASDAQ Biotech UCITS ETF Acc (USD) (IE00BQ70R696)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BQ70R696
SBIO ISIN
Exchange Traded Funds (ETF)
Fondstyp
Invesco
Anbieter
65,43 USD
NAV pro Aktie | 24/06/2026
06/11/2014
Startdatum
Nein
Ausschüttung von Dividenden
CEOGMS
CFI
SBIO
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
NASDAQ Biotechnology Index
Benchmark
0.4 %
Gesamtkostenquote
440,3 Mio. USD
Gesamtes Fondsvermögen | 24/06/2026
440,3 Mio. USD
Aktien-Anlageklasse Volumen | 24/06/2026
Ja
UCITS

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (SBIO)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

SBIO profile

The Invesco NASDAQ Biotech UCITS ETF Acc (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Invesco fund’s base currency is USD and the share class was registered 06.11.2014 with unique ISIN - IE00BQ70R696. Main exchange is London S.E. (USD) and ticker symbol is SBIO. The total expense ratio is 0.4%. The Invesco NASDAQ Biotech UCITS ETF Acc (USD) pays dividends 0 time(s) per year.

Struktur SBIO auf 24/06/2026

Wertpapier Wertpapier
VERTEX PHARMACEUTICALS ORD 8,14%
AMGEN ORD 8%
GILEAD SCIENCES ORD 7,14%
REGENERON PHARMACEUTICALS ORD 4,69%
ALNYLAM PHARMACEUTICALS ORD 2,87%
REVOLUTION MEDICINES ORD 2,64%
BIOGEN ORD 2,15%
ILLUMINA ORD 1,94%
ROIVANT SCIENCES ORD 1,79%
ROYALTY PHARMA CL A ORD 1,76%
MODERNA ORD 1,75%
ARGENX ADR REP ORD 1,72%
UNITED THERAPEUTICS ORD 1,71%
INSMED ORD 1,64%
INCYTE ORD 1,58%
VIATRIS ORD 1,36%
GUARDANT HEALTH ORD 1,33%
NEUROCRINE BIOSCIENCES ORD 1,22%
ASCENDIS PHARMA ORD 1,07%
MEDPACE HOLDINGS ORD 1,07%
JAZZ PHARMACEUTICALS ORD 1,05%
BRIDGEBIO PHARMA ORD 0,99%
EXELIXIS ORD 0,97%
IONIS PHARMACEUTICALS ORD 0,92%
AXSOME THERAPEUTICS ORD 0,89%
MADRIGAL PHARMACEUTI ORD 0,86%
ARROWHEAD PHARMACEUTICALS ORD 0,82%
BIOMARIN PHARMACEUTICAL ORD 0,81%
SUMMIT THERAPEUTICS ORD 0,81%
CYTOKINETICS ORD 0,8%
BIONTECH SE ADR 0,77%
KRYSTAL BIOTECH ORD 0,75%
SANOFI 2 ADR REP ORD 0,7%
BEONE MEDICINES ADS REP ORD 0,67%
NUVALENT CL A ORD 0,66%
TEMPUS AI CL A ORD 0,66%
PRAXIS PRECISION MEDICINES ORD 0,63%
HALOZYME THERAPEUTICS ORD 0,62%
ALKERMES ORD 0,61%
KYMERA THERAPEUTICS ORD 0,6%
APOGEE THERAPEUTICS ORD 0,6%
IMMUNITYBIO ORD 0,6%
PROTAGONIST THERAPEUTICS ORD 0,57%
IMMUNOVANT ORD 0,57%
VAXCYTE ORD 0,57%
SPYRE THERAPEUTICS ORD 0,55%
RHYTHM PHARMACEUTICALS ORD 0,54%
MIRUM PHARMACEUTICALS ORD 0,51%
PTC THERAPEUTICS ORD 0,51%
COGENT BIOSCIENCES ORD 0,47%
SCHOLAR ROCK HOLDING ORD 0,46%
CG ONCOLOGY ORD 0,44%
LIGAND PHARMACEUTICALS ORD 0,42%
TWIST BIOSCIENCE ORD 0,42%
AMNEAL PHARMACEUTICALS CL A ORD 0,4%
XENON PHARMACEUTICALS ORD 0,39%
TRAVERE THERAPEUTICS ORD 0,39%
ABIVAX SA ADR 0,39%
CRISPR THERAPEUTICS ORD 0,38%
CARIS LIFE SCIENCES ORD 0,38%
INDIVIOR PHARMACEUTICALS ORD 0,37%
ORUKA THERAPEUTICS ORD 0,36%
ERASCA ORD 0,34%
DEFINIUM THERAPEUTICS ORD 0,34%
EDGEWISE THERAPEUTICS ORD 0,33%
VERACYTE ORD 0,33%
TANGO THERAPEUTICS ORD 0,31%
10X GENOMICS CL A ORD 0,3%
ACADIA PHARMACEUTICALS ORD 0,29%
DENALI THERAPEUTICS ORD 0,29%
RELAY THERAPEUTICS ORD 0,28%
CRINETICS PHARMACEUTICALS ORD 0,28%
NEWAMSTERDAM PHARMA ORD 0,28%
STRUCTURE THERAPEUTICS ADR 0,27%
BEAM THERAPEUTICS ORD 0,25%
ARCUTIS BIOTHERAPEUTICS ORD 0,25%
DYNE THERAPEUTICS ORD 0,25%
IDEAYA BIOSCIENCES ORD 0,23%
ADAPTIVE BIOTECHNOLOGIES ORD 0,23%
UNIQURE ORD 0,23%
ALUMIS ORD 0,22%
ENLIVEN THERAPEUTICS ORD 0,21%
TARSUS PHARMACEUTICALS ORD 0,21%
ULTRAGENYX PHARMACEUTICAL ORD 0,21%
VERA THERAPEUTICS CL A ORD 0,21%
GRAIL ORD 0,2%
KINIKSA PHARMACEUTICALS INT CL A ORD 0,2%
DISC MEDICINE ORD 0,2%
SUPERNUS PHARMACEUTICALS ORD 0,19%
BIOCRYST PHARMACEUTICALS ORD 0,19%
TREVI THERAPEUTICS ORD 0,18%
LEGEND BIOTECH 2 ADR REP ORD 0,18%
AURINIA PHARMACEUTICALS ORD 0,18%
PHARVARIS N V ORD 0,17%
MBX BIOSCIENCES ORD 0,17%
KODIAK SCIENCES ORD 0,16%
INTELLIA THERAPEUTICS ORD 0,16%
AGIOS PHARMACEUTICALS ORD 0,16%
OCULAR THERAPEUTIX ORD 0,16%
VERICEL ORD 0,16%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.